Gavin Bennett

Gavin Bennett

Company: Bicycle Therapeutics

Job title: Senior Director, Program Team Leader


Workshop C: From Pre-IND to IND – Overcoming Important Regulatory Hurdles to Get into the Clinic 9:00 am - 12:00 pm

Although traditional ADCs now have a developed regulatory framework, the regulatory pathway for next-generation conjugates is still developing. As more next-generation conjugates are being developed this will begin to become clearer, however, there still remains questions around the pre-IND and IND path, as well as core clinical and manufacturing regulatory challenges. This workshop will offer…Read more

day: Pre-Conference Day Track B

The Development of Bicycles as Precision Guided Therape 9:30 am

Bicycles offer the affinity and selectivity of antibodies in a small molecule format Understand how Bicycles targeting the tumor antigens can provide rapid delivery of payloads to tumor cells, whilst limiting exposure to normal tissues Learn about the Bicycle Toxin Conjugates (BTCs) and Tumor-targeted Immune Cell Activators (TICA) that are being developed to offer novel…Read more

day: Scientific Program Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.